Hold’em for Life Oncology Fellowships
Hold’em for Life Charity Challenge has made a generous and transformative commitment to oncology research and education at the University of Toronto’s Temerty Faculty of Medicine and our partner hospitals.
The Hold’em for Life Oncology Fellowships are open to University of Toronto residents and clinical fellows pursuing cancer research at any of the Faculty’s nine fully affiliated teaching hospitals. You can read more about the fellowships and Hold'em for Life Charity Challenge here.
For information on how to apply for a fellowship, visit the awards page.
There have been over 110 Hold’em for Life Oncology Fellowships awarded to date. Below is an overview of each Hold’em Fellow and their research.
Hold’em for Life Oncology Fellows:
Alexandra Acher
Sunnybrook Health Sciences Centre
Project: Histology-Based Radiomics Modeling – Can It Improve Preoperative Assessment of Locoregional Disease in Patients with Pancreas, Biliary, and Liver Cancer?
Said Ahmed Mohammed Al Saifi
Sunnybrook Health Sciences Centre
Project: A phase II trial of stereotactic body radiation therapy (SBRT) for selected stage II or III NSCLC patients ineligible for surgery or radical chemoradiation
Tatianny Araujo Vargas
Sunnybrook Health Sciences Centre
Project: Rare Mutation Melanoma Trial with Encorafenib and Binimetinib
Anouk Benseler
Sunnybrook Health Sciences Centre
Project: Ovarian function and fertility outcomes after oncologic immunotherapy: a population study
Fernando Binder
Mount Sinai Hospital
Project: Life-Threatening Complications of Chimeric Antigen Receptor T-Cell Therapy
Josh Bleicher
Princess Margaret Cancer Centre
Project: Patients’ perceptions of quality-of-life following surgical treatment of advanced peritoneal surface malignancies: a mixed methods study
Adom Bondzi-Simpson
Sunnybrook Health Sciences Centre
Project: Integrating Equity into Quality Metrics for Colorectal Cancer Care: An Analysis of Wait Times for Curative-Intent Surgery
Karanbir Brar
Toronto General Hospital
Project: Defining distinct molecular subtypes of esophageal adenocarcinoma for targeted therapy
Rubens Copia Sperandio
CBRE Hold’em for Life Oncology Fellow
Sunnybrook Health Sciences Centre
Project: Biomarker testing and its implications on treatment responses in advanced prostate cancer patients in a real-world setting
Zachary Coyne
Princess Margaret Cancer Centre
Project: Accelerating Time to Molecular Diagnosis in Early Lung Cancer (AToM)
Ugo Dionne
Lunenfeld-Tanenbaum Research Institute
Project: Kinase translocations in cancer: commonalities and differences in mechanisms of action
Marina Dutra
Hospital for Sick Children
Project: Methylation profiling in Wilms tumor: a link between constitutional genetics and tumor phenotype
Yosef Ellenbogen
Toronto Western Hospital
Project: Dissecting the determinants and dynamics of cellular states promoting glioma evolution
Mitchell Elliot
Princess Margaret Cancer Centre
Project: Acquired pharmacologic vulnerabilities in cyclin dependent kinase 4/6 inhibitor-resistant metastatic estrogen receptor positive breast cancer
Kevin Fan
Sunnybrook Health Sciences Centre
Project: Clinical, dosimetric and pathological biomarkers associated with development of brain metastases in an international multi-institutional cohort of patients treated with metastasis-directed therapy for oligometastatic disease
Italo Fernandes
Sunnybrook Health Sciences Centre
Project: MRI screening for brain metastases among patients with HER2+ stage II or III breast cancer: A multi-centre, single arm phase II clinical trial
Mark Freeman
Sunnybrook Health Sciences Centre
Project: Noninvasive Prediction of HER2 Status of Breast Cancer Brain Metastases with Deep Neural Networks”
Vikas Garg
Princess Margaret Cancer Centre
Project: Engaging ER pathway in Gynecologic Cancers
Inna Gong
Princess Margaret Cancer Centre
Project: Biomarker Development and Optimization of Chimeric Antigen Receptor T-cell Therapy for Lymphoma
Galileo Gonzalez
BMO Hold’em for Life Oncology Fellow
Princess Margaret Cancer Centre
Project: Characterizing the Genomic Landscape of Locally Advanced Pancreatic Cancer
Chloe Gui
Toronto Western Hospital
Project: Single-cell lineage tracing in plexiform neurofibromas and malignant peripheral nerve sheath tumors to assess tumoral heterogeneity and mechanisms of drug resistance
Gopila Gupta
Princess Margaret Cancer Centre
Project: Association of Markers of Inflammation with Clinical Outcomes in Patients with Myeloproliferative Neoplasms (MPNs)
Mathew Hall
Princess Margaret Cancer Centre
Project: A Mixed Methods Analysis of Access to Comprehensive Genomic Profiling Among Lung Oncologists in Ontario
Mercedes Herrera Juarez
Princess Margaret Cancer Centre
Project: Landscape Mapping of Epitopes and T Cell Receptors for Malignant Pleural Mesothelioma (MESO-LANDMARC)
Coralea Kappel
Princess Margaret Cancer Centre
Project: Cardio-oncology referral practices, knowledge, barriers, and facilitators of guidelineconcordant care in breast cancer
Niranjan Khaire
Princess Margaret Cancer Centre
Project: Investigation of hematopoietic stem cell molecular signatures for predicting Clinical Outcomes of Allogeneic Stem Cell Transplant Recipients
Jeongseok Kim
Mount Sinai Hospital
Project: Characterization of the Tumor Microenvironment of Ulcerative Colitis-associated Colorectal Neoplasia with Imaging Mass Cytometry
Alexander Landry
Toronto Western Hospital
Project: A multi-omic approach to radiation resistance in meningioma
Jennifer Leigh
CentreCourt Hold’em for Life Oncology Fellow
Mount Sinai Hospital
Project: Gynecologic Symptoms of Menopause (GSM) During Treatment with Endocrine Therapy: Understanding the Incidence and Impact on Quality of Life in Patients with Breast Cancer
Yuchen Li
Princess Margaret Cancer Centre
Project: IMPROVE (Intelligent Modeling for Predicting and Reducing Overutilization of Visits to the
Emergency departments)
Ronan McLaughlin
Princess Margaret Cancer Centre
Project: A pan-tumor translational prospective study to characterize the intestinal microbiome constitution, and its relationship with the response to anticancer-therapies, related toxicities and the immune profile of these tumors as a novel conceptual biomarker finding model in gastrointestinal, hepatobiliary and non-small cell lung tumors
Karim Mithani
Sunnybrook Health Sciences Centre
Project: Breaking the Barrier: Focused Ultrasound-Mediated Delivery of Doxorubicin in Treating Pediatric Diffuse Intrinsic Pontine Gliomas
Ahmad Mousa
Princess Margaret Cancer Centre
Project: Retroperitoneal Lymph Dissection for Metastatic Nonseminomatous Germ Cell Tumors: Review of Oncologic Outcomes and the Role of Adjuvant Chemotherapy
Carlos Muzlera
Princess Margaret Cancer Centre
Project: Development and Validation of a Medical Oncology Workforce Planning Model in Ontario
Yoshiko Nakano
Hospital for Sick Children
Project: Pediatric cancer predisposition - More effective and less invasive approaches
Inbar Nardi Agmon
Toronto General Hospital
Project: Personalized Medicine in Cardiology-Oncology: Utilizing the gut microbiome and circulating metabolites to predict risk: A Pilot Prospective Cohort Study
David Nguyen
Princess Margaret Cancer Centre
Project: Enhancing patient care for 2SLGBTQ+ individuals through implementation for 2SLGBTQ+ cultural competency training for medical oncologists
David-Dan Nguyen
CMCC/Atrium Hold’em for Life Oncology Fellow
Princess Margaret Cancer Centre
Project: Enhancing equity and mitigating over-diagnosis of prostate cancer through the development and evaluation of machine learning-driven organized prostate cancer screening policies
Daniel Palhares
Sunnybrook Health Sciences Centre
Project: Diffusion Magnetic Resonance Imaging to Detect Adversely Prognostic Tumour Regions in Glioblastoma Patients Undergoing Adaptive Magnetic Resonance-Guided Radiotherapy
Neha Pathak
Princess Margaret Cancer Centre
Project: Using the Cancer Aging and Research Group- Breast Cancer (CARG-BC) predictive model in older adults with early breast cancer: an external validation study
Renee Potashner
Hospital for Sick Children
Project: A Pilot Project to Implement a Digital Comprehensive Psychosocial Screening Tool in Paediatric Oncology
Harkanwal Randhawa
Princess Margaret Cancer Centre
Project: Long-term outcomes of active surveillance for patients with Gleason grade group 2 prostate cancer
Faisal Rashed
Lunenfeld-Tanenbaum Research Institute
Project: Delineating the role of CIP2A-TOPBP1 complex in processing mitotic DNA lesions
Tayler Declan Ross
Sunnybrook Health Sciences Centre
Project: Quantifying Osteosarcopenia Progression with Imaging Biomarkers in Prostate Cancer
Catherine Sarre
Mount Sinai Hospital
Project: Adult soft tissue sarcomas in Mexico: Current patterns of presentation, treatment, and oncologic outcomes
Noor Shakfa
National Bank Hold’em for Life Oncology Fellow
Lunenfeld-Tanenbaum Research Institute
Project: Investigating tumour immune multi-cellular environments to inform therapy selection in pancreatic cancer
Husain Shakil
St. Michael's Hospital
Project: Longitudinal Population-Based Study Investigating Changes in the Epidemiology and Treatment-Related Outcomes of Patients with Spinal Metastases
Pamela Denisse Soberanis Pina
Princess Margaret Cancer Centre
Project: Impact of HPV DNA integration in Cervical Cancer (VEN-HPV)
Jennifer Spiegel
Sunnybrook Health Sciences Centre
Project: Intratympanic N-Acetylcysteine (NAC) injections for prevention of cisplatin-induced ototoxicity in head and neck cancer patients: A multi-centre phase I/II randomized controlled trial.
Scott Strum
Princess Margaret Cancer Centre
Project: Deciphering circulating tumor DNA signatures of primary versus acquired resistance to immunotherapy in advanced cancer patients
Adam Suleman
Princess Margaret Cancer Centre
Project: Assessing the Impact of Marginalization on Outcomes for Patients Undergoing Autologous and Allogeneic Stem Cell Transplantation
Noémie Villemure-Poliquin
Sunnybrook Health Sciences Centre
Project: Treatment Delays in Head & Neck Cancers: A Mixed Methods Study
Catherine Weadick
Princess Margaret Cancer Centre
Project: Radiomics in Gastrointestinal Stromal Tumor (RING) Study
Marian Severin Wettstein
Princess Margaret Cancer Centre
Project: Trimodal Therapy versus Radical Cystectomy for Muscle-Invasive Bladder Cancer: Emulation of a Randomized Controlled Trial Using Observational Data
Talya Wittmann Dayagi
Hospital for Sick Children
Project: Short and long-term outcomes of patients with inherited bone marrow failure syndromes (IBMFS) with and without hematopoietic stem cell transplantation (HSCT): A population-based pan-Canadian cohort study
Tian Xiao
Princess Margaret Cancer Centre
Project: Treatment and Outcomes of Advanced Thyroid Cancer in the Elderly and Frail Population
Alice Zhu
Sunnybrook Health Sciences Centre
Project: Developing a Personalized Model to Predict Symptom Burden in Patients with Gastrointestinal Malignancies
Anudari Zorigtbaatar
Toronto General Hospital
Project: Understanding inequities in HCC cancer care from a comparative health systems perspective
Tatianny Paula Araújo Vargas, Sunnybrook Health Sciences Centre
Project: Rare Mutation Melanoma Trial with Encorafenib and Binimetinib
Carly Barron, Princess Margaret Cancer Centre
Project: Cross tumor-comparison of the tumor immune microenvironment, peripheral immune signatures and response to immunotherapy as a novel conceptual model in aerodigestive tumors
Edward Chen, Lunenfeld-Tanenbaum Research Institute
Project: Immune Modulation in Hippo Pathway Regulated Breast Tumour Microenvironments
Massimo Di Iorio, Princess Margaret Cancer Centre
Project: Exercise and Rehabilitation for People with Cancer: A Survey of Canadian Oncology Residents’ Knowledge and Awareness of Practice Guidelines
Nely Mercy Díaz Mejía, CBRE Hold'em for Life Fellow, Princess Margaret Cancer Centre
Project: A retrospective review of the use of GCSF for patients with GU receiving chemotherapy during the COVID-19 pandemic and implications for the future
Mitchell Elliot, Princess Margaret Cancer Centre
Project: Acquired pharmacologic vulnerabilities in cyclin dependent kinase 4/6 (CDK4/6) inhibitor-resistant hormone receptor positive breast
Ian Hirsch, Princess Margaret Cancer Centre
Project: Profiling of Cancer of Unknown Primary Site, Melanoma, Adnexal, Skin for Optimizing Immunotherapy
Thomas Kennedy, Sunnybrook Health Sciences Centre
Project: Detection of Circulating Tumour DNA before and after Stereotactic Ablative Radiotherapy for Confirmed and Suspected Early Lung Cancer (SABR-DETECT)
Colleen Kerrigan, Sunnybrook Health Sciences Centre
Project: Reflex MammaPrint and BluePrint testing on breast cancer core biopsies: Impact on tumor phenotype classification, perceived provider utility, and process implementation
Jethro Kwong, Silvercore Hold'em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Development of an early warning system for non-muscle invasive bladder cancer recurrence and progression using time-series forecasting with artificial intelligence
Diego Malon Gimenez, Princess Margaret Cancer Centre
Project: Incidence, prevalence, risk factors and impact of fatty liver disease in metastatic HR+/HER2− breast cancer patients in first line of treatment with Aromatase Inhibitors and CDK 4/6
Amy Lu, The Hospital for Sick Children
Project: Describing limited English proficiency (LEP) in paediatric oncology
Adi Nitzan-Luques, The Hospital for Sick Children
Project: Translational in vivo modeling to identify therapeutic opportunities for high-risk neuroblastoma
Daniel Palhares, Sunnybrook Health Sciences Centre
Project: Stimulated Microbubble Radiation Enhancement Treatment in Head and Neck Cancer Patients
Jenny Peng, Princess Margaret Cancer Centre
Project: Understanding the gene expression profile of neuroendocrine carcinoma of genitourinary primaries: a pilot study
Erick Saldanha, Princess Margaret Cancer Centre
Project: Use of targeted therapies in patients with advanced thyroid cancer: efficacy and safety outcomes from a real-world genomically profiled cohort
Marie-Philippe Saltiel, Princess Margaret Cancer Centre
Project: Improving the Transition to Practice Curriculym in the Medical Oncology Training Program
Amit Sharma, Lunenfeld-Tanenbaum Research Institute
Project: Deciphering the role of the Formin / Wnt-PCP axis in breast cancer cell motility and Metastasis
Mariska Sie, The Hospital for Sick Children
Project: DNA-damage response targeting and epigenetic priming to overcome radio-resistance in very high-risk medulloblastoma
Ana Veneziani, Princess Margaret Cancer Centre
Project: Phase I Study of Autologous Epithelial Ovarian Cancer (EOC) Cells Containing Lentivirus Engineering Expression of IL-12
Kevin Wang, Princess Margaret Cancer Centre
Project: Comprehensive genomic, immunologic and metabolomic characterization of the tumour, host, and gut microbiome interaction in hepatocellular carcinoma
Justin Wang, Toronto Western Hospital
Project: Uncovering the epigenetic and transcriptomic biomarkers of response to radiotherapy in meningiomas
Yibo Xue, Lunenfeld-Tanenbaum Research Institute
Project: Studying DNA damage networks in human cancer cells
Rui Miguel Marques Bernardino, Princess Margaret Cancer Centre
Project: Unravelling the potential of extracelular vesicles as biomarkers of intraductal and cribriform prostate cancer
Adom Bondzi-Simpson, Sunnybrook Health Sciences Centre
Project: Integrating equity into quality metrics for colorectal cancer care: an Analysis of wait times for curative-intent surgery
Sanjeev Budhathoki, Lunenfeld-Tanenbaum Research Institute
Project: Development of risk prediction models for early detection and prognosis of aerodigestive cancers
Alberto Hernando Calvo, Princess Margaret Cancer Centre
Project: External validation of the VIGEX gene-expression signature as a novel predictive biomarker for immuno-oncology (IO) treatments
Julian Chavarriaga, Princess Margaret Cancer Centre
Project: miRNAs as potential circulating tumor markers for stratifying and surveilling small testicular masses
Rania Chehade, Sunnybrook Health Sciences Centre
Project: Toward Immunotherapy in breast cancer brain metastases: PD-L1 expression and beyond
Danielle Cuthbert, Princess Margaret Cancer Centre
Project: Process Analysis for the HIMALAYAS Study: Cancer Survivor's Experience with a Supervised Cardio-Oncology Rehabilitation Program
David Cyr, Mount Sinai Hospital
Project: Enhancing Prognostication in Colorectal Cancer: the Role of Clinico-pathologic and Molecular Features Beyond the TNM Staging System
Anirban Das, The Hospital for Sick Children
Project: Gliomas with DNA-replication repair deficiency: How the cell-of-origin, genomic, and epigenetic landscape impact immune-directed therapeutic vulnerability
Ahmed Elmotayam, Lunenfeld-Tanenbaum Research Institute
Project: A New Therapeutic Strategy for Highly Lethal Small Cell Neuroendocrine Cancers
Abdul Rehman Farook, Princess Margaret Cancer Centre
Project: Cancer cachexia and genotype correlations in Pancreatic Ductal Adenocarcinoma
Jesus Fuentes Antras, Princess Margaret Cancer Centre
Project: Tumor-informed ctDNA dynamics in HR+/HER2- metastatic breast cancer patients receiving first-line CDK4/6 inhibitors
Sofia Genta, Princess Margaret Cancer Centre
Project: CP-101 and Atezolizumab in Patients with Advanced Solid TumorS to INterrogate the Gut Microbiota (CASSIN)
Maru Gete, Mount Sinai Hospital
Project: Molecular Testing of Indeterminate Thyroid Nodules for Informed Surgical Management
Samantha Hershenfeld, Princess Margaret Cancer Centre
Project: Clinico-genetic risk stratification of limited stage follicular lymphoma
Amanda Hird, Sunnybrook Health Sciences Centre
Project: Contemporary Risk of Bone Fractures Among Men with Advanced Prostate Cancer on Androgen Deprivation Therapy
Kyle Juraschka, The Hospital for Sick Children
Project: Harnessing CRISPR to identify drivers of medulloblastoma metastasis
Karineh Kazazian, Princess Margaret Cancer Centre
Project: Indocyanine green (ICG) Guided Sentinel Lymph Node Biopsy in Breast Cancer
Colleen Kerrigan, Sunnybrook Health Sciences Centre
Project: Reflex MammaPrint and BluePrint testing on breast cancer core biopsies: Impact on tumor phenotype classification, perceived provider utility, and process implementation
Ravi Kumar, Princess Margaret Cancer Centre
Project: Characterizing the impact of using novel patient-centered pathology reports in clinical practice
Jethro Kwong, Princess Margaret Cancer Centre
Project: Development of an early warning system for non-muscle invasive bladder cancer recurrence and progression using time-series forecasting with artificial intelligence
Lucy Ma, Princess Margaret Cancer Centre
Project: Next-Generation Sequencing in Advanced Thyroid Cancers: Clinical Application and Impact on Patient Outcomes
Louise McLoughlin, Princess Margaret Cancer Centre
Project: Explainable Artificial Intelligence in the diagnosis of Muscle Invasive Upper Tract Urothelial Carcinoma
Gordon Taylor Moffat, Princess Margaret Cancer Centre
Project: Optimizing the Quality of Surveillance in Patients with Completely Resected Gastroenteropancreatic Neuroendocrine Tumours
Consolacion Molto Valiente, Princess Margaret Cancer Centre
Project: Machine learning to estimate the real-world risk of 3-year disease free survival in patients with residual, triple negative breast cancer after neoadjuvant chemotherapy
Daniel Palhares, Sunnybrook Health Sciences Centre
Project: Pilot Investigation of Ultrasound Cell Death Imaging and Spectroscopy as Early Indicators of Response to Radiation Treatment in Prostate Cancer
Sabrina Piedimonte, Princess Margaret Cancer Centre
Project: Predicting Response to Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Using the Rate of Elimination of CA-125 (KELIM Score) and Chemo-Response Score
Nikhil Raghuram, The Hospital for Sick Children
Project: Targeting EZH2 in EBTs: Role of epigenetic modifiers in modulating pluripotency
Gabriel Revon-Riviere, The Hospital for Sick Children
Project: Characterization of MUC16/CA125 expression in pediatric in pediatric soft-tissue sarcomas and pilot study of a first-in-class MUC16/CA125 T-cell engager bispecific antibody
Enrique Sanz Garcia, Princess Margaret Cancer Centre
Project: Study of circulating tumor DNA (ctDNA) kinetics in immuno-oncology (IO-KIN)
Alina Selega, Lunenfeld-Tanenbaum Research Institute
Project: Detecting epithelial-mesenchymal transition states in highly multiplexed imaging data
Mariska Sie, The Hospital for Sick Children
Project: Epigenetic Priming to Overcome Radio-Resistance in Very High-Risk Medulloblastoma
Pavlina Spiliopoulou, Princess Margaret Cancer Centre
Project: Immune Response to COVID-19 Vaccine in immunotherapy (IO) and non-IO Treated Cancer Patients (VIVACIOUS)
Henry Miew Hoon Su, Toronto General Hospital
Project: Age Related Clonal Hematopoiesis and Atherosclerotic Cardiovascular Disease in Cancer Survivors
Michael S. Taccone, The Hospital for Sick Children
Project: Mitochondrial Fission: Targeting the Achilles’ Heel of Glioblastoma
Raj Vikesh Tiwari, Princess Margaret Cancer Centre
Project: Free/Total PSA ratio as a biomarker for PSMA PET positivity in patients with biochemical recurrence post prostatectomy
Randy Van Ommeren, The Hospital for Sick Children
Project: Characterization of the metabolic drivers of grp3 medulloblastoma metastasis
Richard Walker, Sunnybrook Health Sciences Centre
Project: Learning Curves and Volume-Outcome Relationships in Robot-Assisted Surgical Oncology
Irene Xie, Princess Margaret Cancer Centre
Project: Identifying molecular vulnerabilities in pancreatic ductal adenocarcinoma
Jeffrey Zuccato, Princess Margaret Cancer Centre
Project: Lung adenocarcinoma brain metastasis prediction and non-invasive diagnosis using methylation signatures in tissue and plasma
Marie Alt, Mount Sinai Hospital
Project: Optimizing Sexual Health and Emotional Well-Being got Breast Cancer Patients and Survivors
Federico Carini, Mount Sinai Hospital
Project: Venous thromboembolism in hematologic malignancy and hematopoietic cell transplant patients
Douglas Cheung, Princess Margaret Cancer Centre
Project: Seeing Clearly: A Decision Analysis of MRI, PSMA PET/CT, and Biomarker Testing in Early Prostate Cancer Detection
Sarah Cohen-Gogo, The Hospital for Sick Children
Project: PICTURE: PARP Inhibitors and Chemotherapy for patients harbouring TUmours with homologous REcombination repair deficiency: a phase II pilot study
David Cyr, Mount Sinai Hospital
Project: Clinicopathologic and Molecular Predictors of Outcomes Following Salvage Surgery for Locally Recurrent Rectal Cancer
Alexandra Desnoyers, Princess Margaret Cancer Centre
Project: Fragility Index of Approved Cancer Drugs
Grace Egan, Princess Margaret Cancer Centre
Project: Nuclear Hexokinase 2: Mechanism of Regulating Stemness in Acute Myeloid Leukemia
Robert Grant, Princess Margaret Cancer Centre
Project: Predicting Outcomes in Pancreatic Cancer from Clinical and Genomic Data using Machine Learning
Alexander Gregor, Toronto General Hospital
Project: Enhancing sentinel lymph node mapping in lung cancer surgery using a novel liposome-based dual-modality nanoparticle
Keegan Guidolin, Princess Margaret Cancer Centre
Project: Porphysomes for the intraoperative visualization of colorectal lymph node metastases
Dumas Guillaume, Mount Sinai Hospital
Project: The Impact of Critical Illness on Oncology Care Following Critical Care Survival
Fyeza Hasan, The Hospital for Sick Children
Project: Children with Cancer as Participants in End-of-life-Research
Kyle Juraschka, The Hospital for Sick Children
Project: Harnessing CRISPR to identify drivers of medulloblastoma metastasis
Kristen McAlpine, Princess Margaret Cancer Centre
Project: Comparison of OpeN VErsus RoboTic (CONVERT) Partial Nephrectomy Trial- a feasibility randomized control trial
Nick Meti, Princess Margaret Cancer Centre
Project: Machine Learning to estimate risk of 3-year disease-free survival in patients with residual, HER2-positive breast cancer after neoadjuvant chemotherapy and HER2- targeted therapy.
Randy Van Ommeren, The Hospital for Sick Children
Project: Characterization of the metabolic drivers of grp3 medulloblastoma metastasis
Michael Taccone, The Hospital for Sick Children
Project: Mitochondrial Fission: Targeting the Achilles' Heel of Glioblastoma
Abi Vijenthira, Princess Margaret Cancer Centre
Project: Application of the Generalizable Frailty Index using population-based health administrative data in older patients with diffuse large B-cell lymphoma (DLBCL), with further sensitivity analyses using a smaller cohort with detailed pathologic and cancer-specific data
Irene Xie, Princess Margaret Cancer Centre
Project: Identifying molecular vulnerabilities in pancreatic cancer
Marie Alt, Mount Sinai Hospital
Project: Optimizing Sexual Health and Emotional Well-Being got Breast Cancer Patients and Survivors
Zubair Bayat, Mount Sinai Hospital
Project: Toward Streamlining Colon Cancer Care
Oscar Calvillo, Toronto General Hospital
Project: Characterizing Heart And Mind health Post-chemotherapy In Women with early-stage breast cancer (CHAMPION)
Alberto Hernando Calvo, Princess Margaret Cancer Centre
Project: External validation of the VIGEX gene-expression signature as a novel predictive biomarker for immuneoncology (IO) treatments
Hanbo Chen, Sunnybrook Health Sciences Centre
Project: Towards a Better Therapeutic Ratio: The Role of Magnetic Resonance-Linear Accelerator (MR-Linac) in Radiotherapy
Douglas Cheung, Princess Margaret Cancer Centre
Project: Seeing Clearly: A Decision Analysis of MRI, PSMA PET/CT, and Biomarker Testing in Early Prostate Cancer Detection
Sarah Cohen-Gogo, The Hospital for Sick Children
Project: PICTURE: PARP Inhibitors and Chemotherapy for patients harbouring TUmours with homologous REcombination repair deficiency: a phase II pilot study
David Cyr, Mount Sinai Hospital
Project: Clinicopathologic and Molecular Predictors of Outcomes Following Salvage Surgery for Locally Recurrent Rectal Cancer
Alexandra Desnoyers, Princess Margaret Cancer Centre
Project: Fragility Index of Approved Cancer Drugs
Lawson Eng, Princess Margaret Cancer Centre
Project: ONCO-GEMINI: Oncology Continuum General Medicine Inpatient Initiative
Carrillo Estrada, Mount Sinai Hospital
Project: Cardiac Outcomes in Pregnant Cancer Survivors: A Prospective Cohort Study
Sofia Genta, Princess Margaret Cancer Centre
Project: Immune Resistance Interrogation Study (IRIS): evaluating genomic, transcriptomic, epigenetic, immunophenotypic and radiomic profiles associated with primary and acquired resistance to PD1/PD-L1 targeting agents.
Rachel Glicksman, Sunnybrook Health Sciences Centre
Project: Early surrogate measures and predictors of outcome for intermediate risk prostate cancer patients treated with ablative therapies
Robert Grant, SmartCentres Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Predicting Outcomes in Pancreatic Cancer from Clinical and Genomic Data using Machine Learning
Alexander Gregor, Toronto General Hospital
Project: Enhancing sentinel lymph node mapping in lung cancer surgery using a novel liposome-based dual-modality nanoparticle
Keegan Guidolin, CMCC/Atrium Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Porphysomes for the intraoperative visualization of colorectal lymph node metastases
Paulo Kayano, Princess Margaret Cancer Centre
Project: Impact of Proton Pump Inhibitors on prostate cancer diagnosis and outcomes
Rachel Kim, CMCC/Atrium Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Characterization of endometrioid carcinoma of the endometrium: molecular subtype assignment to infirm treatment decisions and improve outcomes
Tristan Knight, RBC Hold'em for Life Oncology Fellow, The Hospital for Sick Children
Project: Re-envisioning the autologous hematopoietic stem cell transplant as immunotherapy
Eyal Lebel, Princess Margaret Cancer Centre
Project: Clinical applications of free DNA in Multiple Myeloma
Jerry Ku, Sunnybrook Health Sciences Centre
Project: Adjuvant 5-aminolevulinic acid-based intraoperative photodynamic therapy of glioblastoma multiforme: A prospective pilot study
Bryan Li, The Hospital for Sick Children
Project: High-throughput drug screening and development of in vivo drug models for pineoblastoma
Shelly Luu, BMO Hold'em for Life Oncology Fellow, Mount Sinai Hospital
Project: Investigation of the Polo-like Kinas 4 Interactome as a Novel Therapeutic Target in Gastric Cancer
Wanda Marini, Katie Hoffman Hold’em for Life Oncology Fellow, Mount Sinai Hospital
Project: The Role of Hedgehog Signaling in Basal-Like Breast Cancer and the Tumor Microenvironment
Kristen McAlpine, Princess Margaret Cancer Centre
Project: Establishing national benchmarks and quality improvement priorities for the surgical care of kidney cancer patients in Canada
Michelle Nadler, Dream Hold’em for Life Oncology Fellow, Women's College Hospital
Project: What are the determinants of breast cancer screening practices for women aged 40-49?
Farshad Nassiri, Toronto Western Hospital
Project: Establishing the utility of a novel plasma-based biomarker to non invasively prognosticate meningiomas
Christopher Noel, Levinsky Waratah Hold’em for Life Oncology Fellowship, Sunnybrook Health Sciences Centre
Project: Symptom Burden as a Predictor of Emergency Room Visits and Unplanned Hospitalizations in Patients with Head and Neck Cancer
Sarah Picardo, Princess Margaret Cancer Centre
Project: Evaluation of the tumour-adjacent microbiota in patients with metastatic genitourinary (GU) cANcers: the URinary and fecal microBiome (URBAN)
Khaled Ramadan, Silverberg Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Photodynamic Therapy during in vivo lung perfusion for treatment of lung metastases
April Rose, Princess Margaret Cancer Centre
Project: Characterizing mechanisms of response and resistance to binimetinib and encorafenib in advanced cancers with non- V600E BRAF mutations: correlative analyses of the BEAVER trail
Abdulazeez Salawu, Mount Sinai Hospital
Project: Circulating Tumor DNA Detection in Soft Tissue Sarcoma (DNATSAR)
Carlos Stecca, Princess Margaret Cancer Centre
Project: Feasibly Integrating Epigenomic and Genomic Liquid Biopsy Biomarkers
Michael Taccone, The Hospital for Sick Children
Project: Mitochondrial Fission: Targeting the Achilles' Heel of Glioblastoma
Abi Vijenthira, The Gerald Schwartz & Heather Reisman Foundation Hold'em For Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Application of the Generalizable Frailty Index using population-based health administrative data in older patients with diffuse large B-cell lymphoma (DLBCL), with further sensitivity analyses using a smaller cohort with detailed pathologic and cancer-specific data
Mathew Voisin, Toronto Western Hospital
Project: Liquid biopsy of gliomas by absolute quantification of IDH mutation
Pei Jye Voon, Princess Margaret Cancer Centre
Project: Measurement of psychometric properties of the Functional Assessment of Cancer Therapy – Immune Checkpoint Modulators (FACT-ICM) health related quality of life tool in patients treated with durvalumab and oleclumab in various solid tumors
Geoff Watson, Princess Margaret Cancer Centre
Project: Evaluating the Integrative Role of Regulatory T Cells, Myeloid-Derived Suppressor Cells, Inflammatory Cytokines and Neutrophil-Lymphocyte Ratio as Biomarkers of Response and Toxicity in Patients with Advanced Stage Cancer Treated with Pembrolizumab
Irene Xie, CIBC Capital Markets Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Identifying molecular vulnerabilities in pancreatic cancer
Zsolt Zador, The Hospital for Sick Children
Project: Exploring the spectrum of cell identities and treatment vulnerabilities in K27M pediatric gliomas
Zubair Bayat, Mount Sinai Hospital
Project: Toward Streamlining Colon Cancer Care
Oscar Calvillo, Toronto General Hospital
Project: Characterizing Heart And Mind health Post-chemotherapy In Women with early-stage breast cancer (CHAMPION)
Vaibhav Gupta, Sunnybrook Health Sciences Centre
Project: Development and external validation of a personalized model to predict survival in esophageal cancer patients
Otto Hemminki, SmartCentres Hold’em for Life Oncology Fellow, Mount Sinai Hospital
Project: Transforming care for high-risk muscle-invasive bladder cancer using fast-tracked new MRI techniques and radiomics to decrease time to cystectomy
Paulo Kayano, Princess Margaret Cancer Centre
Project: Impact of Proton Pump Inhibitors on prostate cancer diagnosis and outcomes
Shelly Luu, BMO Hold'em for Life Oncology Fellow, Mount Sinai Hospital
Project: Investigation of the Polo-like Kinas 4 Interactome as a Novel Therapeutic Target in Gastric Cancer
Wanda Marini, Katie Hoffman Hold’em for Life Oncology Fellow, Mount Sinai Hospital
Project: The Role of Hedgehog Signaling in Basal-Like Breast Cancer and the Tumor Microenvironment
Dave Mealiea, Mount Sinai Hospital
Project: Investigation and Design of Oncolytic Vaccinia Virus-Based Therapies in Colorectal Cancer
Ying Meng, Sunnybrook Health Sciences Centre
Project: Liquid biopsy of brain tumours using MR-guided focused ultrasound-induced blood-brain barrier disruption
Michelle Nadler, Dream Hold’em for Life Oncology Fellow, Women's College Hospital
Project: What are the determinants of breast cancer screening practices for women aged 40-49?
Gregory Nason, CentreCourt Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Comparison of OpeN VErsus RoboTic (CONVERT) Partial Nephrectomy Trial- a feasibility randomized control trial
Farshad Nassiri, Toronto Western Hospital
Project: Establishing the utility of a novel plasma-based biomarker to non invasively prognosticate meningiomas
Sarah Picardo, Princess Margaret Cancer Centre
Project: Evaluation of the tumour-adjacent microbiota in patients with metastatic genitourinary (GU) cANcers: the URinary and fecal microBiome (URBAN)
Jenna Spring, Mount Sinai Hospital
Project: Early Advance Care Planning in Hematologic Malignancies and Hematopoietic Stem Cell Transplants: A Pre-Post Pilot Study
Carlos Stecca, Princess Margaret Cancer Centre
Project: Feasibly Integrating Epigenomic and Genomic Liquid Biopsy Biomarkers